Pulse Biosciences (PLSE) Free Cash Flow (2015 - 2025)
Pulse Biosciences (PLSE) posted quarterly Free Cash Flow of -$14.9 million for Q4 2025, down 61.96% year-over-year from -$39.1 million in Q4 2024, and down 12.36% quarter-over-quarter from -$13.2 million in Q3 2025.
Pulse Biosciences (PLSE) Free Cash Flow (2015 - 2025) Analysis & Trends
Pulse Biosciences' Free Cash Flow history runs 11 years deep, the most recent figure standing at -$14.9 million for Q4 2025.
- In Q4 2025, Free Cash Flow fell 61.96% year-over-year to -$14.9 million; the TTM figure through Dec 2025 stood at -$54.4 million (down 49.66% YoY), while the FY2025 annual figure was -$54.4 million, down 49.66% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$14.9 million, down from -$13.2 million in the prior quarter.
- The five-year high for Free Cash Flow was -$6.6 million in Q1 2023, with the low at -$16.5 million in Q2 2021.
- The 5-year median for Free Cash Flow is -$11.2 million (2021), against an average of -$11.3 million.
- The sharpest annual moves came in 2021 and 2023: Free Cash Flow tumbled 109.21% in 2021, then soared 57.69% in 2023.
- Pulse Biosciences' Free Cash Flow stood at -$12.4 million in 2021, then soared by 35.53% to -$8.0 million in 2022, then advanced by 14.75% to -$6.8 million in 2023, then tumbled by 34.43% to -$9.2 million in 2024, then sank by 61.96% to -$14.9 million in 2025.
- Business Quant data shows PLSE's Free Cash Flow at -$14.9 million in Q4 2025, -$13.2 million in Q3 2025, and -$12.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 948.40 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 633.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 136.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 403.50 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 604.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 80.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 144.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 96.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 181.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.86 Mn |
| Dec 31, 2025 | -14.86 Mn |
| Sep 30, 2025 | -13.23 Mn |
| Sep 30, 2025 | -13.23 Mn |
| Jun 30, 2025 | -12.81 Mn |
| Jun 30, 2025 | -12.81 Mn |
| Mar 31, 2025 | -13.55 Mn |
| Mar 31, 2025 | -13.55 Mn |
| Dec 31, 2024 | -9.18 Mn |
| Dec 31, 2024 | -9.18 Mn |
| Sep 30, 2024 | -9.01 Mn |
| Sep 30, 2024 | -9.01 Mn |
| Jun 30, 2024 | -8.41 Mn |
| Jun 30, 2024 | -8.41 Mn |
| Mar 31, 2024 | -9.78 Mn |
| Mar 31, 2024 | -9.78 Mn |
| Dec 31, 2023 | -6.83 Mn |
| Dec 31, 2023 | -6.83 Mn |
| Sep 30, 2023 | -10.51 Mn |
| Sep 30, 2023 | -10.51 Mn |